LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3950
0.00 (0.00%)
At close: Mar 20, 2026
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 47.88 million as of March 20, 2026. Its market cap has increased by 16.75% in one year.
Market Cap
47.88M
Enterprise Value
69.49M
Revenue
26.80M
Ranking
n/a
PE Ratio
17.41
Stock Price
0.40
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 47.88M, a decrease of -22.36%. That is a compound annual growth rate of -7.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 47.88M | 12.86% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioNxt Solutions | 71.25M |
| Decibel Cannabis Company | 69.25M |
| Leef Brands | 67.07M |
| Planet 13 Holdings | 65.63M |
| Vext Science | 55.23M |
| ZYUS Life Sciences | 45.64M |
| C21 Investments | 44.81M |
| iAnthus Capital Holdings | 34.86M |